SEC 13F Intelligence

Foresite Capital Management IV, LLC / ABUS

Foresite Capital Management IV, LLC’s Arbutus Biopharma Corp Position

Does Foresite Capital Management IV, LLC own Arbutus Biopharma Corp (ABUS)? Not currently — the last reported position was 3.33M shares worth $10M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$10M
Q3 2020
Shares
3.33M
% of Portfolio
+2.35%
Quarters Held
4
position exited

Position History ABUS

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q2 ’19: $1MQ2 ’19Q4 ’19: $10MQ4 ’19Q3 ’20: $10MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20203.33M$10M+2.35%
Q4 20193.71M$10M+4.44%
Q2 2019608.2K$1M+0.36%
Q1 2019804.4K$3M+1.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management IV, LLC’s full portfolio or all institutional holders of ABUS.